explore -WSS

explore

author：knowledge 2025-09-27 22:59:28 - browse：51

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： South Korea throws huge K

WSS

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Friends ask where James Watson's attitudes about race came from

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Why failed clinical trials don’t always spell doom for a new drug

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

House passes resolution saying Israel isn't a 'racist or apartheid state'

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

knowledge

Bright Health sells Medicare Advantage business to Molina

US soldier in North Korean custody after crossing DMZ line

After affirmative action ruling, medical educators look to 'holistic review'

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Psychedelics group wrestles with new pharma identity

Twill hunts for pharma partner to market its depression app

Drug repurposing or repositioning? The language matters

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

State Dept. review finds Biden bears some blame for Afghanistan failures

Johnson & Johnson sues to stop Medicare negotiation

knowledge

US soldier in North Korean custody after crossing DMZ line

Police still searching for prisoner who escaped from NYC hospital

Drastic changes should bring profitability, startup health insurers say

Biden administration sends mixed signals on US soldier who crossed into North Korea

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

hotspot

entertainment

knowledge

entertainment